GCPj's report, Conducting Clinical Trials in Emerging Markets is the essential resource for strategists and global trial planners. It enables useful comparisons to be drawn on key performance indicators, such as population statistics, healthcare provision, clinical trial activity and FDA inspection findings.
It focuses on pharmaceutical clinical trials, and is laid out by region, and then by country, making it invaluable for anyone involved in global clinical research programmes.
Conducting Clinical Trials in Emerging Markets market research report provides a detail review of the sector with 201 pages.